| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/31/2008 | CA2690710A1 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 12/31/2008 | CA2690708A1 Vaccine |
| 12/31/2008 | CA2690707A1 Vaccine |
| 12/31/2008 | CA2689960A1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 12/31/2008 | CA2689941A1 Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 12/31/2008 | CA2689569A1 Linear expression constructs for production of influenza virus particles |
| 12/31/2008 | CA2689408A1 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease |
| 12/31/2008 | CA2689064A1 Sequence based engineering and optimization of single chain antibodies |
| 12/31/2008 | CA2688667A1 Methods of treating rsv infections and related conditions |
| 12/31/2008 | CA2688589A1 Intradermal hpv peptide vaccination |
| 12/31/2008 | CA2685533A1 Vaccine against clostridium perfringens |
| 12/30/2008 | US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 12/30/2008 | US7470777 Compositions and methods related to modified retroviral vectors for restricted, site specific integration |
| 12/30/2008 | US7470775 Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins |
| 12/30/2008 | US7470774 Anti-pro1477 antibodies |
| 12/30/2008 | US7470772 Antibody that specifically binds to Chemerin receptor ligand precursor |
| 12/30/2008 | US7470674 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 12/30/2008 | US7470521 fusion proteins comprising a Receptor for Advanced Glycation Endproducts; treating a condition characterized by activation of an inflammatory cytokine cascade comprising administering such fusion proteins |
| 12/30/2008 | US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 12/30/2008 | US7470431 Administering a therapeutic amount of a botulinum toxin into the prostate gland of a patient with prostate cancer, thereby alleviating a symptom of prostate cancer or its treatment |
| 12/30/2008 | US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization |
| 12/30/2008 | US7470429 Pretargeting enzyme to mammalian target site, administering cytotoxic drug known to act at target site, or prodrug form thereof which is converted to the drug in situ, which drug is detoxified then reverted by enzyme to toxic form at site |
| 12/30/2008 | US7470428 Compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is |
| 12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
| 12/30/2008 | CA2353048C Pharmaceutical composition useful in the prevention or treatment of peptic ulcers |
| 12/30/2008 | CA2263816C Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 12/30/2008 | CA2245545C Vaccines against varicella zoster virus gene 63 product |
| 12/30/2008 | CA2197683C Method for preparing an influenza virus, antigens obtained and applications thereof |
| 12/30/2008 | CA2144425C Microparticules bearing antigens and their use for the introduction of humoral and cell responses |
| 12/30/2008 | CA2132349C Chimeric receptor genes and cells transformed therewith |
| 12/30/2008 | CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules |
| 12/28/2008 | CA2634144A1 Novel fish pathogen |
| 12/25/2008 | US20080319173 Blood group antigen fusion polypeptides and methods of use thereof |
| 12/25/2008 | US20080319167 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 12/25/2008 | US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide |
| 12/25/2008 | US20080318313 Method to Prevent Graft Rejection Using TGF-Beta to Induce T Suppressor Cells |
| 12/25/2008 | US20080318275 Hepatitis C virus asialoglycoproteins |
| 12/25/2008 | US20080318254 PSCA antibodies and hybridomas producing them |
| 12/25/2008 | US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 12/25/2008 | US20080317865 Quench liquids and washing systems for production of microparticles |
| 12/25/2008 | US20080317863 Pharmaceutical Compositions Useful in the Transmucosal Administration of Drugs |
| 12/25/2008 | US20080317838 Liposomal Vaccine Compositions Comprising a Polysaccharide Antigen and a Protein Adjuvant |
| 12/25/2008 | US20080317837 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 12/25/2008 | US20080317825 Pharmaceutical Preparation that can be Administered Orally for Treating Fish, Production Method for Said Preparation and Use of the Latter |
| 12/25/2008 | US20080317809 Use of K -252a and Kinase Inhibitors for the Prevention or Treatment of Hmgb1-Associated Pathologies |
| 12/25/2008 | US20080317787 Anti-Malaria Vaccine |
| 12/25/2008 | US20080317786 Genetically Modified Babesia Parasites Expressing Protective Tick Antigens and Uses Thereof |
| 12/25/2008 | US20080317785 Vaccine |
| 12/25/2008 | US20080317784 Immunogenic Compositions Containing Anthrax Antigen, Biodegradable Polymer Microparticles, And Polynucleotide-Containing Immunological Adjuvant |
| 12/25/2008 | US20080317783 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317782 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317781 protecting non-wounded fish against coldwater disease caused by non-attenuated Flavobacterium psychrophilum comprising adminstering the fish by mass immersion an amount of an isolated, live attenuated, rifampicin-resistant Flavobacterium psychrophilum |
| 12/25/2008 | US20080317780 Viral vaccine and method for preparation thereof |
| 12/25/2008 | US20080317779 Hiv Tat-Cd4 Hybrid Molecules and Methods of Use Thereof |
| 12/25/2008 | US20080317778 Modified vaccinia ankara virus variant and cultivation method |
| 12/25/2008 | US20080317777 Cdna Construct Of Salmonidae Alphavirus |
| 12/25/2008 | US20080317776 Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor |
| 12/25/2008 | US20080317775 Bacterial Antigens and Uses Thereof |
| 12/25/2008 | US20080317773 Conjugates that contain the homeodomain of antennapedia |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317771 Anti-Clusterin Oligoclonal Antibodies for Diagnosis and Prediction of the Aggressiveness of Tumours, Diagnostic Method and Related Kits |
| 12/25/2008 | US20080317770 Induction of immunological tolerance |
| 12/25/2008 | US20080317769 Vaccine Composition Comprising Alpha-Galactosylceramide as an Adjuvant For Intranasal Administration |
| 12/25/2008 | US20080317768 Bioconjugated nanoparticles |
| 12/25/2008 | US20080317766 Costimulatory Molecules and Uses Thereof |
| 12/25/2008 | US20080317765 Method for Removal of Toxins from Mucosal Membranes |
| 12/25/2008 | US20080317764 Antibodies against 25-hydroxyvitamin d |
| 12/25/2008 | US20080317763 Regulation of Metalloprotease Cleavage of Cell Surface Proteins |
| 12/25/2008 | US20080317762 Bacterial Contact Inhibition and Methods Therefor |
| 12/25/2008 | US20080317761 Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage |
| 12/25/2008 | US20080317760 Compositions and Methods for Diagnosing and Treating Cancer |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317758 Polypeptide variants with altered effector function |
| 12/25/2008 | US20080317757 Human monoclonal antibody binding to hGM-CSF and its antigen binding portion |
| 12/25/2008 | US20080317756 Antibodies to Chemokine Alpha-5 |
| 12/25/2008 | US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317753 Selecting patients for therapy with a her inhibitor |
| 12/25/2008 | US20080317752 Inhibition of Tumorigenesis by Inhibition of a6b4 Integrin |
| 12/25/2008 | US20080317751 Idiotype Vaccination with Bispecific and Multispecific Immunoglobulin Molecules |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317749 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment |
| 12/25/2008 | US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 12/25/2008 | US20080317747 Recombinant anti-cd30 antibodies and uses thereof |
| 12/25/2008 | US20080317746 Anti-Il2 Antibodies |
| 12/25/2008 | US20080317745 Methods of diagnosing, treating, or preventing plasma cell disorders |
| 12/25/2008 | US20080317744 Indole and Benzimidazole Derivatives |
| 12/25/2008 | US20080317743 Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene And Non-Human Animal Containing The Human Artificial Chromosome Capable Of Genetic Transmission |
| 12/25/2008 | US20080317742 Biomarkers of francisella infection |
| 12/25/2008 | US20080317741 Biomarkers For Anti-Nogo-A Antibody Treatment in Spinal Cord Injury |
| 12/25/2008 | US20080317740 Use of Nk Cell Inhibition to Facilitate Persistence of Engrafted Mhc-I-Negative Cells |
| 12/25/2008 | US20080317739 Method for Treating Skeletal Disorders Resulting from Fgfr Malfunction |
| 12/25/2008 | US20080317738 Mylks as Modifiers of Branching Morphogenesis and Methods of Use |
| 12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
| 12/25/2008 | US20080317716 Antigen, nucleic acid that encodes fusion protein; therapy, prevention of tuberculosis infections |
| 12/25/2008 | US20080317715 Anti-bacterial agents |
| 12/25/2008 | US20080317710 Methods For Treating Autoimmune or Demyelinating Diseases |
| 12/25/2008 | US20080317706 Targeted Conjugates and Radiation |
| 12/25/2008 | US20080317670 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 12/25/2008 | US20080317667 Compositions and methods for inhibiting growth of smad4-deficient cancers |